Continuing clozapine treatment despite neutropenia David EspositoFrédéric RouillonFrédéric Limosin Review Article 30 November 2004 Pages: 759 - 764
Pharmacoepidemiology and the “Impact Factor” Emilio J. Sanz Special Article 03 December 2004 Pages: 765 - 772
Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis K. SkrętkowiczJ. SkrętkowiczA. Sysa-Jędrzejowska Pharmacogenetics 24 November 2004 Pages: 773 - 778
A pharmacokinetic study comparing single and repeated oral doses of 20 mg and 40 mg omeprazole and its two optical isomers, S-omeprazole (esomeprazole) and R-omeprazole, in healthy subjects M. Hassan-AlinT. AnderssonK. Röhss Pharmacokinetics and Disposition 01 December 2004 Pages: 779 - 784
Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects Ayse GelalDilara BalkanNeal L. Benowitz Pharmacokinetics and Disposition 11 December 2004 Pages: 785 - 790
Effect of erythromycin on metabolism of quetiapine in Chinese suffering from schizophrenia Kun-Yan LiXin LiHuan-De Li Pharmacokinetics and Disposition 14 December 2004 Pages: 791 - 795
Structure and markers of appropriateness, quality and performance of drug treatment over a 1-year period after hospital discharge in a cohort of elderly patients with cardiovascular diseases from Germany Sebastian HarderPhilipp FischerHorst Baas Pharmacoepidemiology and Prescription 01 December 2004 Pages: 797 - 805
Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management? Meret Martin-FacklamJens RengelshausenWalter E. Haefeli Pharmacoepidemiology and Prescription 14 December 2004 Pages: 807 - 811
Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C Study Nathalie Lechevallier-MichelMarion Gautier-BertrandOn behalf of the 3C Study group Pharmacoepidemiology and Prescription 14 December 2004 Pages: 813 - 819
Agranulocytosis associated with dipyrone (metamizol) Luisa IbáñezXavier VidalJoan-Ramon Laporte Pharmacoepidemiology and Prescription 03 December 2004 Pages: 821 - 829
Indicators of prescribing quality in drug utilisation research: report of a European meeting (DURQUIM, 13-15 May 2004) JL HovenFM Haaijer-RuskampR.H. Vander Stichele Conference Report 09 December 2004 Pages: 831 - 834
Levetiracetam in the treatment of vascular chorea: a case report Marco D’AmelioGraziella CallariGiovanni Savettieri Letter to the Editors 03 December 2004 Pages: 835 - 836